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The kidney is affected by many chemicals. Some of the chemicals may even contribute to end-
stage renal disease and thus contribute considerably to health care costs. Because of the large
functional reserve of the kidney, which masks signs of dysfunction, early diagnosis of renal
disease is often difficult. Although numerous studies aimed at understanding the mechanisms
underlying chemicals and drugs that target various renal cell types have delivered enough
understanding for a reasonable risk assessment, there is still an urgent need to better understand
the mechanisms leading to renal cell injury and organ dysfunction. The increasing use of in vitro
techniques using isolated renal cells, nephron fragments, or cell cultures derived from specific
renal cell types has improved our insight into the molecular mechanisms involved in nephrotoxicity.
A short overview is given on the various in vitro systems currently used to clarify mechanistic
aspects leading to sublethal or lethal injury of the functionally most important nephron epithelial
cells derived from various species. Whereas freshly isolated cells and nephron fragments appear
to represent a sufficient basis to study acute effects (hours) of nephrotoxins, e.g., on cell
metabolism, primary cultures of these cells are more appropriate to study long-term effects. In
contrast to isolated cells and fragments, however, primary cultures tend to first lose several of
their in vivo metabolic properties during culture, and second to have only a limited life span (days
to weeks). Moreover, establishing such primary cultures is a time-consuming and laborious
procedure. For that reason many studies have been carried out on renal cell lines, which are easy
to cultivate in large quantities and which have an unlimited life span. Unfortunately, none of the
lines display a state of differentiation comparable to that of freshly isolated cells or their primary
cultures. Most often they lack expression of key functions (e.g., gluconeogenesis or organic anion
transport) of their in vivo correspondents. Therefore, the use of cell lines for assessment of
nephrotoxic mechanisms will be limited to those functions the lines express. Upcoming molecular
biology approaches such as the transduction of immortalizing genes into primary cultures and the
utilization of cells from transgenic animals may in the near future result in the availability of highly
differentiated renal cells with markedly extended life spans and near in vivo characteristics that
may facilitate the use of renal cell culture for routine screening of nephrotoxins. - Environ Health
Perspect 106(Suppl 2):559-569 (1998). http://ehpnetl.niehs.nih.gov/docs/1998/Suppl-2/
559-569pfaller/abstract.html
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Introduction
Exposure to drugs and chemicals often
results in toxicity to living organisms. We
must recognize the fact that not all com-
pounds are equally toxic to all parts of a
living system because the toxic actions of
many compounds are manifested in spe-
cific organs. These organs are known as
target organs oftoxicity. This concept has
developed into the evaluation of toxicants
via their target organ specificity.
Several factors determine the suscepti-
bility of a particular organ to toxicity.
These factors include the pharmacokinetics
ofthe compound, the metabolic fate ofthe
compound, and the target organ's ability to
respond to the toxic insult. Many organs,
including the kidney, are capable ofmetab-
olizing chemicals to toxic reactive interme-
diates. The in situ metabolic activation of
chemicals results in selective toxicity. These
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reactive intermediates can initiate toxicity
via binding to cellular macromolecules or
via generation of reactive oxygen species,
which may lead to peroxidative damage of
functionally crucial cellular structures such
as membranes or nucleic acids.
The kidneys are dynamic organs and
represent the major control system main-
taining body homeostasis, i.e., water and
electrolyte balance. Although they comprise
less than 1% oftotal body mass, they receive
about 20% ofthe resting cardiac output.
The nature ofrenal structure and function
renders the kidneys especially susceptible to
toxic xenobiotics. The high rate ofblood
perfusion and the well-developed transport
systems for ions and solutes, as well as the
capability to recover water and thereby con-
centrate the solutes to be excreted from the
body, make the kidneys extremely vulnera-
ble to xenobiotic-induced toxicity. This is
perhaps best illustrated by the fact that end-
stage renal disease (ESRD) represents a
major burden to European health care sys-
tems. The health care costs for diagnosed
ESRD patients in Europe amount to more
than 3500 million European currency units
per year. Approximately 30% of ESRD
results from infectious or genetic diseases
and approximately 20% result from thera-
peutic agents (1). The majority (50%) of
the diagnosed cases ofESRD, however, are
of unknown etiology (Table 1). Current
consensus suggests that chemicals and drugs
probably play a significant role in those
degenerative conditions for which there
currently is no documented etiology.
It is difficult to establish the etiology of
these cases of ESRD because humans are
exposed to many potentially nephrotoxic
chemicals, any one ofwhich may take up
to several decades to produce clinical
symptoms. This is especially so with renal
disease, as it is difficult to diagnose at an
early stage when causality could be more
clearly understood.
Table 1. Causes and costs of end-stage renal disease
in Europe.
Costs to
Percentage Cause Europea
20% Therapeutic agents 711
and chemicals
30% Disease, microorganism, 1067
genetic disorders
50% Unknown etiology 1778
Total All causes 3556
"In million European currency units.
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Role of Nephron
Heterogeneity
in Nephrotoxicity
A number of normal biochemical and
physiologic patterns can be identified that
make the cells ofthe kidney, compared with
those ofother organs, especially susceptible
to ischemic or toxic insults. The major
activity ofthe epithelial cells ofthe nephrons
(uriniferous tubules), the kidney's func-
tional units, is reabsorption ofNa+ from the
blood plasma filtrate produced in the renal
glomeruli. This process represents the
driving force for reabsorption ofwater and
the coupled uptake oforganic solutes such
as sugars and amino acids. Reabsorption of
sodium against an electrochemical gradient
Cortical nephron
Proximaltubularcell
(S-1,S-2segment)
is active and mediated by the basolaterally
localized Na,K-ATPase, a pump fueled by
cellular adenosine triphosphate (ATP)
derived predominantly from oxidative
metabolism ofthe epithelial cells (2). The
linear correlation between renal oxygen con-
sumption and Na+ reabsorption is generally
assumed to result from direct coupling
between energy providing metabolism and
energy consuming transport processes and
illustrated by the morphologic layout of
renal epithelial cells along the various
nephron segments (3) (Figure 1).
The major source ofrenal epithelial cell
energy is oxidative breakdown ofmetabolic
substrates. However, in addition to aerobic
energy production, other metabolic path-
ways such as glycolysis deliver significant
Collecting ductceOl
(principal cell)
Figure 1. Schematic of two nephrons (cortical and juxtamedullary). The cell types shown are restricted to those
most widely used for either isolation or establishment of primary cultures: a proximal tubular cell from the convo-
luted portion, a cell from the distal convoluted tubule, and a principal cell from the cortical collecting duct.
quantities of metabolic energy for renal
function (4,5). Enzymes ofthe glycolytic
pathway are confined to the distal nephron
portions, which makes cells there relatively
resistant to oxygen deficiency as compared
to proximal tubular cells. The capability to
de novo generate glucose is restricted to the
proximal nephron (6), which can also oxi-
dize a-ketoglutarate, glutamine, glutamate,
malate, and succinate, but not glucose and
lactate, to CO2 and water. In contrast, cells
ofthe medullary thick ascending limb can
oxidize glucose and lactate as well as gluta-
mate, a-ketoglutarate, and palmitate.
However, they are unable to utilize succi-
nate or malate (7). Because substrate oxi-
dation along the nephron is dependent on
the distribution ofthe respective enzymes
(8), distal nephron portions predominantly
will use glucose for maintenance oftheir
cellular ATP whereas proximal nephron
portions preferentially use glutamine. The
mammalian kidney further shows a
remarkable substrate specificity and selec-
tively extracts these substrates from the
blood supply in considerable amounts.
Long and short chain fatty acids, as well as
citrate and ketone bodies, complete the
substrates listed above as major energy
sources for renal work (4).
The anatomical, functional, and
biochemical differences among the various
cell types alongthe nephron implythat these
cells will each respond in a characteristic
manner to exposure to chemical toxicants or
to pathologic conditions such as hypoxia or
ischemia. Indeed, the kidneys are prime tar-
gets ofseveral drugs, toxic xenobiotics, or
chemicals; first, because ofthe high blood
flowrate andsecond, becauseofthe presence
ofcellular transport systems that facilitate
concentration ofthese compounds within
the nephron epithelial cells. Because ofthe
heterogeneous distribution oftransport sys-
tems and different abilities to either bioacti-
vate or detoxify xenobiotics, the different
cell populations (and therefore the various
regions within the kidney) will not all dis-
play the same degree ofdamage after expo-
sure. Rather, distinct cell populations may
be particularly susceptible to a specific class
ofchemicals and resistant to injury from
another class ofchemicals. Renal epithelial
cells ofthe proximal nephron are target sites
for many nephrotoxic chemicals because ofa
large number oftransport systems (8) and
because ofthe presence ofxenobiotic metab-
olizing enzymes such as cytochrome P450,
reduced nicotinamide adenine dinucleotide
phosphate-cytochrome C reductase,
glucuronyl transferase, sulfotransferases,
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glutathione S-transferases (induding cysteine
conjugate 3-lyase), monooxygenases, and
prostaglandin H synthase (8-11). In addi-
tion, intracellular concentrations ofreduced
glutathione (GSH) and GSH-dependent
enzymes are highest in this nephron segment
(8). Therefore, injuries that alter cellular
redox state, such as oxidative stress during
ischemia-reperfusion injury, will vary along
the nephron. Variations are also expected
according to thedifferences incellularenergy
metabolism, which displays a similar distrib-
ution pattern to that outlined for GSH.
Indeed, early proximal nephron segments
(S-2 segments) appear to be more resistant to
oxidative injury than their outer medullary
portions (S-3 segments) and the thick
ascendinglimb ofHenle'sloop (8).
The cellular and molecular mechanisms
ofa limited number ofnephrotoxic lesions
are now sufficiently well understood
to allow rational risk assessment to be
undertaken. A list ofthe major classes of
nephrotoxins known to affect animals and
humans follows:
Therapeutic agents
* Analgesics
- Nonsteroidal antiinflammatory drugs
- Paracetamol
* Antibiotics
- Aminoglycosides
- Cephalosporins
- Amphotericin B
- Tetracyclines
- Puromycin
* Lithium
* Urographic contrast media
* Anticancer drugs
- Cisplatin
- Adriamycin
- Ifosphamide
* Immunosuppressive agents
- Cyclosporin A
* Heroin
Chemicals
* Ethylene glycol
* Organic solvents
- Volatile hydrocarbons
- Chloroform
- Lighthydrocarbons
* Bipyridylic herbicides
* Mycotoxins
- Ochratoxin-A
- Citrinin
- Orellanine
* Silicone
* Metals
- Arsenic
- Bismuth
- Cadmium
- Chromium
- Germanium
- Gold
- Lead
- Mercury
- Uranium
Following chemical injury, tissue
responds dynamically and, where possible,
repairs occur rapidly. The repair potential
decreases as the changes in renal cellular
function move from biochemical perturba-
tion to primary and secondary injury
(Figure 2). At the same time the capability
to compensate injury decreases. If the
changes are rapid, acute renal insufficiency
or failure is the result. If the injurious
processes develop slowly, chronic degenera-
tivechanges occurandthecapability to com-
pensate for functional changes-the organ's
functional reserve-declines steadily.
The kidney's role in regulating body
homeostasis may mask functional changes
that are transient and hence go unnoticed.
Because offunctional and morphologic
heterogeneity, the cellular response to
injury differs depending on the region of
the kidney affected. Although the majority
ofthe epithelial cells lining the uriniferous
tubules repair rapidly, the cells belonging
to the renal glomerulus, which is responsi-
ble for ultrafiltration ofblood plasma and
production ofprimary urine, and special
cells contained in the renal medulla,
involved in concentration ofthe primary
urine, are less capable or are unable to
repair. Repeated insults to regions that do
not repair or show only slow repair will
progressively erode those cells over years
and lead to chronic renal failure and
ESRD. Nephrons undergoing insults have
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Figure 2. Scheme ofthetarget-selective nature of renal
injury and the subsequent cascade of degenerative
changes.
a substantial capacity for compensating
injury-renal functional reserve. This
makes the assessment of the degree of
functional impairment difficult. Standard
function tests like the determination of
the glomerular filtration rate or the reab-
sorption of water and electrolytes are
indicative of extensive damage and mea-
sure change only when the functional
reserve capacity has been eroded beyond a
critical value. Substances to be eliminated
by renal excretion, such as urea or creati-
nine, will increase their blood level only
if 70 to 80% ofthe renal epithelial mass
has been lost (Figure 3). At present no
procedure for assessment of renal func-
tional reserve is available. The destruction
of one renal epithelial cell type could (if
compensation for lost function is not
possible) compromise the adequate func-
tion ofother cells and thus trigger a cas-
cade of degenerative changes in adjacent
or even more distant cells. As long as cell
damage is below a certain threshold or is
sublethal, functional disturbance may
become measurable only if sensitive
enough methodologies are applied. These
signs of injury are the release of enzymes
or other protein molecules from damaged
renal cells into the urine, which poten-
tially offer the noninvasive diagnosis of
renal damage (12). However, these pro-
cedures are to the best of our knowledge
only useful for detecting acute events.
Such injuries are usually either repaired
or compensated.
Only if the duration of insults is
sustained and damage to particular renal
cell types is not repaired will renal failure
develop over a prolonged period. Under
these conditions slow progressive changes
occur and the kidney is unable to function
fully. This is most often recognized by the
inability to eliminate end products of
metabolism such as urea or creatinine
from the body fluids via urinary excretion.
Again, these changes are apparent at an
advanced stage ofrenal dysfunction.
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Figure 3. Schematic ofthe staging of renal failure.
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Monitoring oflow- and high-molecu-
lar-weight proteins in the urine can iden-
tify injury of the filtration units, the
glomeruli, or the uriniferous tubule epithe-
lium relatively early during development of
chronic renal failure.
In VitroScreening
and Mechanistic Studies
Caused by the target organ-selective nature
ofmany nephrotoxic xenobiotics, in vitro
methods have become an invaluable tool for
understanding mechanisms of action.
However, there is need to carefully match
the in vitrosystem and the conditions to the
question being asked. In this context there
are problems not yet readily solved, e.g., the
most relevant concentration ofa chemical.
Ofimportance is that the intact kidney pos-
sesses the capability to concentrate several
compounds during urine formation to a
degree that may exceed plasma concentra-
tion by a factor of 102 to 103, and that this
process cannot can be assessed analytically
for everypotentially toxic compound.
A number ofend points, e.g., enzyme
leakage from cells; alterations in solute
transport across cultured renal epithelial
cell layers; their energy metabolism; the
synthesis, expression, and turnover of a
number ofspecific cellular marker mole-
cules; and light and ultrastructural pathol-
ogy, have been applied to the in vitro
techniques outlined in more detail below.
HigherOrderSystems
The Isolated Perfused Kidney. The
isolated perfused kidney ([IPK]; usually
taken from rat or rabbit), either perfused
cell free or in the presence oferythrocytes
(13), is the most appropriate system for
studying potentially nephrotoxic xenobi-
otics (14) when tubulovascular integrity is
required. This system is not influenced by
higher order regulatory systems (e.g., ner-
vous, hormonal, and blood-borne factors).
The IPKenables precise control ofthe con-
centration ofcompound that is being stud-
ied. However, it is not a system to be used
for routine examinations. The disadvan-
tage, compared to studies ofthe kidney in
situ, is that renal function is maintained for
only a short period oftime (approximately
2 hr), although the life span can be pro-
longed considerably by the use ofsterile
tubing or the addition ofoxyphoretic com-
pounds or erythrocytes (13). Iftissue oxy-
genation is provided only by physically
dissolved oxygen (i.e., blood-free perfu-
sion), the IPK already represents a hypoxic
model of renal function and is further
characterized by perfusate flow rates far
above those in vivo and in situ. Filtration
rate, sodium, solute, and water reabsorp-
tion, on the other hand, are below the
usual in vivovalues. Three modes ofperfu-
sion can be utilized: single path perfusion,
recirculation ofthe perfusate, or recircula-
tion and dialysis ofthe perfusate. Dialysis
often is combined with oxygenation (15).
IsolatedPerfued Nephrons. Isolated
perfused nephrons (16), or more precisely
nephron segments, have delivered valuable
insights to functional (transport, electrical
properties) characteristics ofcertain nephron
segments. However, this technique is not
reallysuitable for routine in vitronephrotox-
icity studies. Investigation ofmicrodissected
nonperfused segments has provided knowl-
edge on localization ofenzyme systems (8),
metabolic pathways, and the distribution
of receptors that are now being used to
confirm the site oforigin ofrenal cellular
systems after isolation.
Renal Tissue Slices. One ofthe earliest
in vitro techniques applied and still widely
used for the study oftransport and toxicity
is the renal tissue slice (17). A substantial
portion of our current knowledge on
nephrotoxic mechanisms has been derived
from this technique. However, renal slices
present several disadvantages. First, slices
contain a heterogeneous cell population,
which makes assessment of functional
changes upon exposure to a toxicant in a
specific cell type quite cumbersome.
Second, many ofthe cells and the exposed
surfaces are damaged from cutting. Third,
slices still represent acomplex conglomerate
ofvarious cell types interacting with each
other and do not ensure that every cell of
interest is exposed to nutrients and oxygen
to the same extent. Although precision cut-
ting (18) and prolonged incubations (19)
have been developed, the use of isolated
and enriched fractions ofdefined nephron
segments (tubular fragments) and nephron
cells types remains superior for studies of
mechanistic aspects ofnephrotoxicity.
Isolated Glomeruli, Tubular
Fragments, andRenal Cells. Freshly iso-
lated glomeruli, glomerular mesangial or
epithelial cells (20), and fragments or cells
from defined nephron segments (21) have
been used to assess acute effects ofchemi-
cals. The isolation is based on forcing finely
minced tissue (either untreated or subjected
previously to enzymatic digestion) into oxy-
genated buffer through a series ofsieves
(22). The purity of the glomerular and
tubular preparation is high and can be fur-
ther improved by subjecting the fragments
to percoll isopycnic centrifugation (21).
Alternatively, preparation yield can be
improved by infusion ofiron partides prior
to the separation oftubular fragments to
completely remove the vascular compo-
nents andglomeruli by magneticseparation
(23). The glomerular and tubular prepara-
tions obtained can then be submitted to a
number of unspecific but sensitive end
points oftoxicity testing as well as to a
number oftest procedures specific for the
respective cell type ofinterest.
For glomeruli, sensitive end points
would include metabolism and thesynthesis
ofproteoglycan, collagen, and fibronectin;
with proximal and distal nephron fragments
or isolated cells, studies of the effect of
nephrotoxins on metabolism and transport
studies can be undertaken. Such studies
have been performed with fragments and
cells isolated from rat, rabbit, pig, dog, and
human kidneys. The advantage ofusing
fragments is that the in vivo architecture of
the epithelium is retained. Therefore, alter-
ations in nephron segment-specific bio-
chemical functions after injury induced by
toxic xenobiotics can be easily obtained,
leading to abetterunderstanding ofnephro-
toxic mechanisms. Using this approach
numerous studies on mechanistic aspects of
nephrotoxicity have been conducted, e.g.,
cephalosporins, angiotensin-converting
enzyme inhibitors (24), or cisplatin (25), to
give just a few examples. Similarly, isolated
cells ofdifferent nephronal origin have been
usedfor that purpose (26).
A limitation ofthis method is that the
fragment ends represent damaged sites,
thus the life span is limited to a few hours.
Isolated nephron cells suffer from the same
disadvantage. For longer lasting studies,
primary cultures ofcells are needed.
Cell Culture Models
in Nephrotoxicity Testing
Cell culture techniques as a tool for in vitro
nephrotoxicity studies have gained more
importance over the past two decades. This
is largely due to improved methodologies
for growing homogeneous cultures ofrenal
cells. Two major strategies have been
pursued: the use of primary cultures of
glomerular mesangial and epithelial cells
and renal epithelial cells from various
sites along the nephron, and the use of
permanent renal epithelial cell lines.
Depending on the retention ofadequate
renal cellular functions, which interfere
with xenobiotic or drug action (27), renal
cell cultures have the advantage ofproviding
an experimental model uninfluenced by
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higher order regulatory systems. For
successful applications of cell and tissue
cultures in renal physiologic and toxico-
logic studies, the following requirements
must be met:
* Cells should retain the polar architec-
ture and junctional assembly ofepithe-
lia and should express the proper polar
distribution ofmembrane enzymes and
transport systems (28), resulting in the
exhibition ofvectorial transport of
solutes and water manifested by the for-
mation ofdomes (29) and the genera-
tion oftransepithelial electrophysiologic
characteristics (such as a spontaneous
transepithelial potential difference)
resulting from a certain transepithelial
resistance (Figure 4) and short circuit
current (30).
* The cellular uptake of xenobiotics
should occur from either the apical or
basolateral side as observed in vivo (31).
* Cultured cells should retain nephron
segment-specific characteristics, distinct
metabolic and transport properties, and
hormone responsiveness (32).
These requirements arebest, though not
completely, met by primary cultures of
renal epithelial cells during the early period
after initiation ofcultures. None of the
continuous renal epithelial cell lines used,
however, fully express all the needed differ-
entiated functions known from the ancestor
cell(s) in vivoand in situ (32).
Obtaining primary cultures from the
kidney is somewhat hampered by the fact
that there are at least 15 to 20 cell types
that comprise the kidney and the nephron,
respectively (33). One must ensure that
homogeneous cultures have been obtained
before anystudy can begin (34).
Despite this difficulty, primary cultures
of proximal nephron epithelium from
various species have been developed, i.e.,
mouse (35), rat (36,37), rabbit (38), and
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Figure 4. Effects of 200 pM CdCI2 on the transepithe-
lial resistance and paracellular permeability of LLC-PK,
monolayers grown on a microporous support.
pig (39). Although cells in primary culture
tend to dedifferentiate within hours, the
characteristics of those cells are usually
closer to the in vivo situation as compared
to cell lines.
The methods ofisolation used are bulk
isolation ofnephron fragments or ofcells
by the methods described above (mechani-
cal disruption, sieving, digestion, and
isopycnic centrifugation). The enriched
tubular segments or cell types must then be
submitted to appropriate media to either
maintain proliferation or to select for
specific cell types.
Precise knowledge of the segmental
metabolic (4,40) and hormonal (41,42)
properties along the mammalian nephron
allows application ofspecific metabolic tis-
sue culture conditions to select the nephron
cell type of interest. D-Amino acid (D-
valine)-containing culture media can be
used to select for cells that express D-amino
acid oxidase activity and prevent the culture
overgrowth by fibroblasts (43). Glucose-free
pyruvate-supplemented culture media will
provide growth only for gluconeogenesis-
competent proximal tubular cells (44-46).
For the isolation ofpapillary collecting duct
cells, their ability to resist a hypoosmotic
shock was used to remove noncollecting
tubule cells from apapillarydigest (47).
The most sophisticated metabolic
and endocrinologic approach developed
to specifically select certain cell types
is the design of serum-free hormone-
supplemented culture media (48). Today,
hormonally defined media descriptions
are available for culturing cells of almost
all nephron segments ofthe most widely
used mammalian species (34,36,49-51)
including human (52).
Bulk isolation can be combined with
immunodissection and immunoselection,
an innovative protocol in the setup ofrenal
primary cultures. This method uses specific
antibodies as immunoaffinity reagents to
isolate populations of different renal cell
types. As the number ofpolyclonal and/or
monoclonal antibodies directed against cell
surface antigens unique to different renal
cell types steadily increases [a set of cell-
specific monoclonal antibodies has already
been described (53-55)], this immuno-
logic procedure will become a widespread
tool in establishing primary cultures of
defined subpopulations ofcells, especially
from distal and cortical collecting tubule
portions (56,57). The most advanced
methodology to establish ultrapure primary
cultures ofproximal and distal tubular cell
populations was recently described by
Helbert (58), who used immunodissection
in combination with flow cytometry to
establish renal primary cultures ofproximal
tubular S-1, S-2, and S-3 segment cells
from the human kidney.
A more laborious method is the visual
selection of individual tubular segments
(16) and outgrowth under appropriate
culture conditions (34).
One ofthe disadvantages ofestablishing
renal primary cultures is that there is still a
considerable gap in available information
with respect to markers that can be used to
unambiguously identify the respective in
situ ancestor cell (32), in particular those of
glomerular origin, after bulk isolation of
cells by centrifugation. Furthermore, the
situation is complicated by the fact that
cells tend to quickly dedifferentiate as they
are maintained in culture.
Furthermore, not all nephron cells
isolated so far can be passaged during pri-
mary culture either because ofdedifferenti-
ation or because of the unavailability of
adequate culture media. For example,
growth ofprimary cultures ofrat proximal
tubules is extremely difficult (59). Some
improvement has been achieved by utiliz-
ing microporous growth supports (60) that
ensure nutrient access from the apical as
well as the basolateral side of cultured
monolayers. In addition, coating the
growth substrates with extracellular matrix
molecules such as collagen I, collagen IV,
fibronectin, laminin, or commercially
available mixtures of these compounds
(e.g., Matrigel, Becton Dickinson Labware,
Bedford, MA) (61) appears to improve
adhesion, proliferation, and differentiation
ofcells in culture. Despite the limitations
outlined, renal primary cultures represent a
reliable though not easy to handle strategy
to study basic renal cellular functions and
their modulation by nephrotoxicants (62).
Primary cultures have been successfully
used to study in vitro effects ofcisplatin,
gentamycin, cephalosporins, cysteine conju-
gates, butylhydroperoxide, mercuric chlo-
ride, and cadmium chloride. (37,63-66).
The majority of in vitro nephrotoxicity
studies, however, have been performed on
permanent or continuous renal epithelial
cell lines, which have been powerful tools
in the study ofnephrotoxicity in vitro. The
most widely used lines and their sites of
origin are discussed below (Table 2). In
addition to many advantages, such as the
possibility oflong-term exposure under
controlled conditions, the unlimited life
span, and the lack of time-consuming
isolation procedures, cell lines suffer from
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Table2. Continuous renal epithelial cell lines.
Cell line Animal derived from Nephron segment of origin
LLC-PK1 Yorkshire pig Proximal nephron
OK North American opossum Proximal nephron
JTC-12 Monkey Proximal nephron
MDCK Dog (cockerspaniel) Collecting duct
A6 Xenopus laevis Distal tubule/collecting duct
Abbreviations: LLC-PK1, porcine cell line; MDCK, Madin-Darby canine kidney; OK, opossum cell line.
some drawbacks. Although they have
retained a number ofdifferentiated func-
tions from their in vivo ancestor cells (32),
they have dedifferentiated in culture. As a
result, cells daimed to be ofproximal tubu-
lar origin exhibit a combination ofproper-
ties characteristic ofdifferent parts ofthe
nephron. Two cell lines that are often used
as models for the proximal nephron are the
porcine cell line (LLC-PKI) and the opos-
sum kidney (OK) cell line. The LLC-PKI
cells lack expression ofthe enzyme fructose-
1,6-bisphosphatase, rendering them inca-
pable ofgluconeogenesis, which is a key
metabolic pathway in proximal nephron
cells (38). In addition, LLC-PKI cells are
not responsive to parathyroid hormone and
lack a probenecid-sensitive organic anion
transporter (67). OK cells, on the other
hand, display little y-glutamyltranspepti-
dase and lack alkaline phosphatase; both
enzymes are considered markers for the
proximal nephron (32). To improve this
situation our laboratory succeeded in devel-
oping gluconeogenic strains ofboth cell
lines by adaptation ofcells to glucose-free
media (45,46). It may be speculated from
these results that by using appropriate cul-
ture conditions, including the well-defined
extracellular matrix, continuous cell lines
could be redifferentiated to some extent.
Cellular and molecular biologytechnologies
such as cell fusion or transfection tech-
niques could be used to reexpress lost func-
tions, e.g., specific transporters or enzymes
orperhaps evenspecific receptors.
A combination of the advantages of
a continuous cell line with the better dif-
ferentiation of primary cultures can be
obtained by immortalization ofthe latter.
Immortalization ofprimary proximal tubu-
lar cell cultures has been achieved in several
ways (68). Proximal nephron cell lines
have been produced by targeted oncogene-
sis in transgenic mice using a pyruvate
kinase-SV40(T) antigen hybrid gene (69).
Transduction ofthe SV40 large T antigen
has also been used to establish cell lines
from ratprimaryproximal nephron cell cul-
tures ofthe Wistar Kyoto rat (70) and the
rabbit (71,72). Immortal human proximal
tubular cell lines have further been
generated by transduction with human
papilloma virus (HPV 16) E6/E7genes
(73). Using a hybrid adeno 12-SV40 vector
(74), successful immortalization of rabbit
(75) and human proximal primary cultures
was achieved (76). It remains to be estab-
lished whether these newly developed lines
have maintained all the desired characteris-
tics oftheir in vivo precursor cells and are
able to retain their functional characteristics
through multiple passages.
Culture Conditions for in Vitro
Nephrotoxicity Testing
Culture media composition, including
serum, hormones, growth factors, culture
substrata, and extracellular matrix compo-
nents, substantially influence the expres-
sion ofspecific morphologic features and
functions and thus the degree ofcell differ-
entiation. The expression of membrane
enzymes and transport systems varies sig-
nificantly with culture duration (77). It is
therefore essential to precisely define the
culture conditions for each cell line used
and for each functional parameter studied
in physiologic or toxicologic experiments.
Another major factor influencing cell
shape, size, and degree ofdifferentiation is
the culture substratum, either the extracellu-
lar matrix (78) or the physical tissue culture
support (79). The degree ofmorphologic
and functional differentiation ofepithelial
cells from different tissues increases consid-
erably when the epithelia are cultured on
permeable surfaces, thereby providing free
access oftissue culture medium to the baso-
lateral membrane surface (79). This tech-
nique ofculturing transporting epithelia
represents a prerequisite for studying epithe-
lial dysfunction for in vitro nephrotoxicity
testing (80).
Physiologic and Biochemical
Functions in the Assessment
of in VitroNephrotoxicity
A major route through which xenobiotic
compounds are processed for excretion in
the kidney is conjugation with GSH
resulting in the formation ofmercapturic
acids (81). This process is associated with
the formation ofhighly reactive nephro-
toxic compounds (82). In particular, GSH
and cysteine S-conjugates have been iden-
tified as nephrotoxins. In several studies,
cysteine S-conjugate transport and toxic-
ity have been elaborated in vitro on LLC-
PKI cells derived from the pig proximal
nephron (83) and ratproximal primarycul-
tures (84). LLC-PK1 cells respond to toxic
GSH and cysteine S-conjugates and bio-
transformed cysteine S-conjugates respond
to toxic mercapturates. Furthermore, these
conjugates are taken up by a basolateral
amino acid transport system (83). Recently,
mercapturic acid formation was also shown
in OK cells (85). Thus, cultured epithelial
cells may serve as model systems to study
aspects of renal biotransformation (86)
and the resulting nephrotoxicity and
nephrocarcinogenicity (87). Nephrotoxic
and mutagenic cysteine conjugates are acti-
vated by the enzyme cysteine conjugate I-
lyase to reactive acylating compounds that
covalently bind to cellular macromolecules.
In LLC-PK1 cells, S-(1,2-dichlorovinyl)-L-
cysteine induced mRNA for c-fos and c-
myc, which could be blocked in part by
reducing agents. Buffering ofthe elevated
intracellular Ca2+ induced by the cysteine
S-conjugate could reduce c-myc but not c-
fos induction (88). Thus toxicity resulting
from bioactivated xenobiotics appears to
selectively trigger intracellular signaling
pathways that have pronounced effects on
gene expression, e.g., the DNA damage-
inducible gene gadd 153 (89). Depletion
of cellular glutathione by reactive elec-
trophiles can activate transcription ofthe
hsp 70 gene family (90). Moreover,
nephrotoxic xenobiotics at sublethal con-
centrations seem to alter expression and
release ofgrowth factors such as fibroblast
growth factor type-1 and epidermal
growth factor (91), which may thereby
trigger accelerated repair ofrenal epithe-
lium (92). Transforming growth factor
beta-i, on the other hand, seems to sup-
press repair (spreading and proliferation) of
mercury and dichlorovinyl-L-cysteine trig-
gered damage in rabbit primary proximal
tubular cultures (66).
The recent observation ofthe expression
of the multidrug transporter P-glycopro-
tein (93) in renal epithelial cell lines (94),
normally present in the apical membrane
of the proximal tubule (95), opens new
ways to study multidrug resistance ofrenal
cells and the potential renal elimination of
chemotherapeutic agents.
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End Points of in Vitro
Toxicity Testing
Cultured renal epithelia have been
successfully used as model systems to
study the cytotoxic action of nephrotoxic
compounds (32).
Maintenance of monolayer integrity
following the administration of a toxic
xenobiotic can be monitored easily by
using light microscopy analogous to
histopathology. Cell integrity can further
be determined by measuring the release of
marker enzymes of the various cellular
compartments into the culture medium, as
in urine analysis. The enzymes determined
are usually lactate dehydrogenase (80), N-
acetylglucosaminidase, glutamate dehydro-
genase, y-glutamyltranspeptidase, or
alkaline phosphatase (81). One should
keep in mind, however, that the toxic com-
pound studied may also inhibit the activity
ofthe marker enzyme (96).
Other parameters that can be used to
ascertain the nephrotoxic action ofxeno-
biotics are those indicative ofthe integrity
of transport functions of the cultured
epithelium. These parameters include the
microscopic observation ofdomes (97),
measurement ofepithelial leakage ofindica-
tor compounds (98), and monitoring of
transepithelial electrophysiologic parame-
ters in Ussing-type chambers (99). These
parameters are the spontaneous transepithe-
lial potential difference, the transepithelial
resistance, the ion transport-generated short
circuit current, and the anion-to-cation per-
meability ratio as a measure ofthe shunt
path perm-selectivity ofthe epithelium. In
particular, these parameters seem to pro-
vide the most sensitive measures ofepithe-
lial permeability and thus of the barrier
function ofthe cultured epithelium (100).
The latter parameter in particular has
been successfully applied for leaky epithelia
such as the proximal nephron (101).
Because ofthe lowtransepithelial resistance
(100-400 Qxcm2) ofmost ofthe cultured
epithelia and the mammalian proximal
tubule, accurate measurements of the
transepithelial resistance are difficult to
perform and are highly dependent on the
geometry of the Ussing-chamber device
and on the geometry and reproducibility of
the electrode positioning, respectively
(102). Thus, quantification of transport
and its alteration by toxic xenobiotics by
means ofelectrophysiologic techniques is
hampered by the very low spontaneously
generated transepithelial potentials and resis-
tances. Despite these facts the differential
effects of reactive oxidants on apical and
basolateral membrane domains and
epithelial conductance of Madin-Darby
canine kidney (MDCK) monolayers have
been studied (103). The effects of phor-
bol ester tumor promoters on epithelial
tight junctions (104) and the disruption
of intercellular junctions by cadmium
(105) have also been studied on LLC-PKI
epithelia using this approach.
Furthermore, electrophysiologic
parameters obtained at the single cell level
can be used to assess the cytotoxic action of
xenobiotics (106). Recently, the method of
continuously recording the cell membrane
potential ofcultured cells with intracellular
microelectrodes was applied to elucidate the
mechanism ofheavy metal toxicity in LLC-
PK1 cells (107). Measurements of cell
membrane fluidity may provide additional
information on epithelial membrane func-
tion (108). The Na+-dependent uptake of
glucose (109) and the transepithelial glu-
cose flux were used as sensitive parameters
ofapical membrane function of injured
cultured renal cells (110).
Other parameters that have been
successfully used to elaborate nephrotoxic-
ity in experimental animals, including the
measurement ofcell metabolism and intra-
cellular ion homeostasis, can also be applied
in in vitrostudies ofcultured renal cells.
The key role ofintracellular calcium in
the pathogenesis of renal cell injury in
acute renal failure is well established (111).
Measurements ofcytosolic calcium concen-
trations in cultured renal cells (112) permit
the study of perturbations of calcium
homeostasis under different nephrotoxic
conditions (113), although the effects of
gentamicin on cytosolic calcium are still
controversial (114).
As a metabolic parameter, the level of
cellular ATP, the main energy source for
renal cellular and transepithelial transport
(2), is one ofthe best candidates to assess
the metabolic and thus the functional state
ofnormal and injured renal cells (106). A
highly sophisticated but noninvasive
method to monitorsrenal cell metabolism
and cellular ATP levels in vivo is nuclear
magnetic resonance spectroscopy. The in
vitro application ofthis technique (115)
permits the study of the metabolism of
freshly isolated and cultured renal epithelial
cells (116).
In addition to all these technical
approaches, the morphologic assessment of
cell damage at light microscopic and ultra-
structural levels will still provide valuable
tools in studies of renal cell injury (80).
The application of electron microscopy
techniques on cultured renal cells allows
comparison ofxenobiotic-induced cell dam-
age in vitrowith the situation found in vivo,
e.g., the effects ofgentamycin (80,114),
cadmium (105), and mycotoxins (117) on
the ultrastructure ofcultured cells.
Future Outlook
New promising techniques are currently
under development that may improve the
applicability ofrenal epithelial primary cul-
tures. Cells grown on microporous sup-
ports under continuous perfusion of
culture media appear to better maintain
the differentiated state over prolonged peri-
ods instead ofproviding good proliferative
properties (118). Furthermore, continuous
medium perfusion may lead to the reex-
pression of lost functions in continuous
cell lines. This would permit the culture of
freshly isolated human and animal cells
under nearly organotypic conditions. It
would further allow the use ofsuch cul-
tures for subchronic nephrotoxicity testing
and still enable assessment ofall possible
toxicity end points. Coculturing renal
epithelial cells with either endothelial or
immune cells under perfusion conditions
would allow testing of important signal
molecules (119) (released from coculture
partner cells such as cytokines) that are
used in therapy (interferons, interleukins,
immune cell growth factors) and produced
by the biotechnology industry. Because of
the high species specificity of these latter
compounds, in vitro test systems based on
human cells (primary or continuous) will
become mandatory to judge toxic side
effects and therapeutic risks, as testing on
animal models will be impossible.
Nephrotoxic side effects ofxenobiotics
can be tested by cell culture techniques.
The two most important applications are
screening of newly synthesized drugs or
environmental contaminants suspected of
exerting adverse effects on the kidney, and
investigation of the mechanistic aspects
leading to renal cell injury. Especially with
respect to the latter, renal epithelial cul-
tures offer the possibility ofeasy access to
the object ofinterest, the cell lines are pro-
vided in nearly unlimited amounts, and
they match their site ofnephronal origin
reasonably well. In this context, continu-
ous renal cell lines represent the experi-
mental system of choice at present. They
are easy to grow, maintain, and handle, are
commercially available (e.g., from the
American Type Culture Collection,
Rockville, MD), and retain most of the
basic functions of their ancestor cell, at
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least in case ofpermanent proximal and
collecting duct cells (LLC-PKI, OK, JTC-
12, MDCK, A6). Another advantage is
that an enormous amount of information
about culture conditions and differenti-
ated functions (e.g., metabolism, trans-
port, and hormone responsiveness) is
available from the literature (32). A disad-
vantage is the fact that cell lines may suffer
from loss ofone or the other in vivo and
in situ functions as a result ofprolonged
cultivation. Under these circumstances, or
if one of the lost functions seems to be
the predominant target for a nephrotoxic
xenobiotic under investigation, the more
laborious and difficult application ofpri-
mary cultures must be done. In addition,
one must keep in mind that continuous
cell lines are heterogeneous, and multiple
cell types might be present in an uncloned
wild-type culture.
Therefore, methods should be developed
to reexpress the lost functions or to tailor
new cell lines more closely matching the
cell type oforigin in continuous cell lines.
Such an enterprise may include several cell
biology techniques already available.
The most simple approach would be
adaptation to culture conditions that
more closely resemble the in vivo environ-
ment of the respective cell type. As men-
tioned, omission or drastic reduction of
glucose and replacement against pyruvate
in the media used for cultivation ofLLC-
PK1 cells enables reexpression of gluco-
neogenesis (45,46). Fusion of cells of
continuous cell lines (120) stemming
from the same in vivo ancestor cell ofdif-
ferent species and with different retain-
ment of cellular functions, i.e., metabolic
pathways, transport systems, or hormone
receptors, may be used to establish new
continuous lines more closely resembling
the characteristics of the cell type of ori-
gin. Fusion ofcells from primary cultures
with cells from continuous lines delin-
eated from the same nephron cell or
nephron segment may help to either
immortalize the respective primary culture
or help to reexpress lost functions within
the continuous cell type.
Genetic approaches (68,121) may
deliver another route to establish new, more
natural permanent cell lines. Transfection
with different but defined genes will be one
ofthe important tools (68,122).
These strategies should even offer the
possibility ofestablishing cell lines express-
ing most or all ofthe functions ofhuman
renal epithelia. However, all ofthese trials
demand careful selection procedures to iso-
late the fused hybridoma, the mutated, or
the transfected cells.
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